OVARIAN CARCINOSARCOMA
Clinical trials for OVARIAN CARCINOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN CARCINOSARCOMA trials appear
Sign up with your email to follow new studies for OVARIAN CARCINOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare, deadly cancer: drug combo trial launches
Disease control Recruiting nowThis study is for people with a rare and fast-growing cancer of the uterus or ovary called carcinosarcoma that has spread or come back after chemotherapy. It compares a new combination of two drugs (dostarlimab and niraparib) against each drug alone or standard chemotherapy. The …
Matched conditions: OVARIAN CARCINOSARCOMA
Phase: PHASE2, PHASE3 • Sponsor: ARCAGY/ GINECO GROUP • Aim: Disease control
Last updated May 17, 2026 02:20 UTC
-
New pill shows promise in battling Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new oral drug, VLS-1488, in people with advanced solid tumors that have not responded to other treatments. The goal is to find a safe dose and see if it can shrink tumors or slow cancer growth. About 200 adults with specific cancers like ovarian, lung, or breas…
Matched conditions: OVARIAN CARCINOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Volastra Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 02:19 UTC
-
Promising combo therapy targets fluid buildup in recurrent ovarian cancer
Disease control Recruiting nowThis study tests whether adding an experimental drug (APL-2) to standard immunotherapy (pembrolizumab) and/or a targeted therapy (bevacizumab) can better control fluid buildup and tumor growth in people whose ovarian, fallopian tube, or peritoneal cancer has returned. About 60 ad…
Matched conditions: OVARIAN CARCINOSARCOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 15, 2026 11:53 UTC